cancer research and data themed icons, with the letters "AI" in the middle
October 20, 2024 3:15 p.m. - 4:15 p.m. CT

Warren A. Kibbe, Ph.D.; Christopher Lieu, M.D.; and Travis Zack, Ph.D.

Hear Drs. Kibbe, Lieu, and Zack discuss a new era of technological development that researchers like you are using in the fight against cancer. This session will be one of many during the 2024 Association of American Cancer Institutes (AACI)/Cancer Center Administrators Forum (CCAF) Annual Meeting.

A large hexagon shape formed from 7 smaller hexagons, with a different icon inside each, representing the various data types in the cancer research data commons.
October 16, 2024 - October 17, 2024

Join us to reflect on the last 10 years of CRDC accomplishments and discover what lies ahead for this data science infrastructure! Informative session topics will address interoperability and data governance, data search and discovery, partnership updates, and how the CRDC contributes to research studies.

Headshot of Fabian J. Theis
October 16, 2024 11:00 a.m. - 12:00 p.m. ET

Fabian J. Theis, Ph.D.

Attend this webinar to learn how artificial intelligence (AI) is transforming science, giving cancer researchers, like you, new ways to simulate complex phenomena by modeling single-cell data.

Three circles showing a patient and doctor, laptop with a cloud icon, and researchers at the bench, transposed over an abstract background.
October 15, 2024 - October 16, 2024 ET

Join researchers and experts from across the public/private sector as they attend the second annual symposium in October 2024. Be a part of the conversation that drives advances in cancer research through broad data sharing and collaborative science.

Blue and green border and interconnected data point icon. Text reads, "sitc" society for immunotherapy of Cancer. AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series"
October 15, 2024 1:00 p.m. - 2:00 p.m. ET

C. ‘Harris’ Floudas, M.D., DMSc, M.S., and Zhiyong Lu, Ph.D.

Explore how artificial intelligence can help analyze electronic health record (EHR) data, which can lead to improved design of immunotherapy clinical trials and effective potential patient matching. This webinar is part of the 2024 SITC-NCI Computational Immuno-oncology Webinar Series, which focuses on the application of AI in immuno-oncology.

Computer screen displaying a brain image next to graphs and charts.
October 11, 2024 12:00 p.m. - 1:00 p.m. ET

Maryellen Giger, Ph.D.

In this upcoming NIH Data Sharing and Reuse Seminar, hear about the impact of the Medical Imaging and Data Resource Center (MIDRC) on clinical artificial intelligence (AI) and patient care.

Profile photo of a small boy. High-tech looking lines and dots are superimposed over the image, denoting the use of technology in helping to address childhood brain tumors.
October 09, 2024 - October 11, 2024

Kenneth Aldape, M.D.; Warren A. Kibbe, Ph.D., FACMI; Henry Rodriguez, Ph.D.; and Shannon Silkensen, Ph.D.

Attend this 3-day summit hosted by the Children’s Brain Tumor Network (CBTN) to learn more about how data and technology are helping advance research in childhood cancers.

A network connecting three user icons on a dark blue background.
October 08, 2024 1:00 p.m. - 2:00 p.m. ET

Cari Kitahara, Ph.D., and Choonsik Lee, Ph.D.

Learn about the CCDI-supported study, NCI Pediatric Proton and Photon Therapy Comparison Cohort. Drs. Cari Kitahara and Choonsik Lee invite you to discuss how to help maximize the potential of this resource for future research studies and inform clinical practice.

decorative data and AI-themed icons, with the letters "AI" in the middle
October 02, 2024 2:00 p.m. - 3:00 p.m. ET

Tanna Nelson, Ph.D.

Hear panelists—including NCI CBIIT’s Dr. Tanna Nelson—address key questions concerning the use of artificial intelligence (AI) in government agencies.

four people examining a laptop
September 27, 2024 7:30 a.m. - 5:00 p.m. ET

This NIH-Department of Energy workshop will help you leverage computational modeling, translate novel medical isotopes, and develop improved radiopharmaceutical theranostics for cancer.